Back to
Los Angeles Capital Management LLC
TGTX
Showing 8 of 23 quarters
Position history for
Los Angeles Capital Management LLC's holdings in TG Therapeutics, Inc.
Yes. Los Angeles Capital Management holds 10,728 shares of TGTX (TG Therapeutics), worth $589,396, as of its Q2 2026 13F filing. It reduced the position by 13,643 shares (-56.0%) from Q1 2026. Los Angeles Capital Management has held TGTX since Q1 2022, across 18 quarterly 13F filings.
Current Value
$589,396
Current Shares
10,728
Total Value Change
-$2.3M
Total Shares Change
-112,673
Quarter-by-Quarter History